The Different Effects of Nucleotide and Nucleoside Analogues on the Prognosis of HBV-Related HCC After Curative Resection.
Xiaoyun ZhangChuan LiTianfu WenLunan YanJiayin YangHong TangChangli LuPublished in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2020)
In patients with HBV-related HCC, nucleotide analogues but not nucleoside analogues significantly reduced HCC recurrence and improved overall survival after R0 hepatic resection.